GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Public ClinicalTrials.gov record NCT00358566. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
"Primovax" - A Phase III Trial Comparing GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Advanced Un-Resectable Pancreatic Cancer.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To investigate the efficacy of GV1001 in sequential combination with gemcitabine in locally advanced and metastatic adenocarcinoma of the pancreas.
Study identification
- NCT ID
- NCT00358566
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 360 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Jul 31, 2008
- Completion
- Jul 31, 2008
- Last update posted
- May 18, 2008
2006 – 2008
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama Mitchell Cancer Institute | Mobile | Alabama | 36688 | — |
| Genesis Cancer Center | Hot Springs | Arkansas | 71913 | — |
| Scripps Clinic Torrey Pines | La Jolla | California | 92037 | — |
| Desert Hematology Oncology Medical Group, Inc. | Rancho Mirage | California | 92270 | — |
| The Center for Hematology-Oncology | Boca Raton | Florida | 33486 | — |
| Tampa General Hospital Usf Digestive Disorders Centre | Tampa | Florida | 33606 | — |
| Palm Beach Cancer Institute | West Palm Beach | Florida | 33401 | — |
| Portneuf Cancer Center | Pocatello | Idaho | 83204 | — |
| Oncology Hematology Associates of Central Illinois, PC | Peoria | Illinois | 61615 | — |
| Hematology Oncology Specialists, Covington | Covington | Louisiana | 70433 | — |
| Berskhire Hematology Oncology PC | Pittsfield | Massachusetts | 01201 | — |
| Billings Clinic | Billings | Montana | 59101 | — |
| Carolinas Hematology Oncology Associates | Charlotte | North Carolina | 28203 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Toledo Community Hospital Oncology Program | Toledo | Ohio | 43617 | — |
| Southwest Regional Cancer Center | Austin | Texas | 78705 | — |
| Mary Crowley Medical Research Center (MCMRC)Texas Oncology-Presbyrerian Hospital of Dallas | Dallas | Texas | 75231 | — |
| Mary Crowley Medical Research Center, Worth St. | Dallas | Texas | 75249 | — |
| Oncology Consultants, PA | Houston | Texas | 77024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00358566, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2008 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00358566 live on ClinicalTrials.gov.